IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model

BACKGROUND: Prostate cancer is one of the most common adult malignancies in men, and nearly all patients with metastatic prostate cancer can develop and receive resistance to primary androgen deprivation therapy (ADT), a state known as metastatic castration-resistant prostate cancer (mCRPC). Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dawei, Shao, Yuan, Zhang, Xiang, Lu, Guoliang, Liu, Boke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961333/
https://www.ncbi.nlm.nih.gov/pubmed/31937346
http://dx.doi.org/10.1186/s12967-019-02206-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961333/
https://www.ncbi.nlm.nih.gov/pubmed/31937346
http://dx.doi.org/10.1186/s12967-019-02206-w

Ejemplares similares